Identification of in vitro metabolites of boldenone using Camel liver microsomes – A HR-LCMS approach
![](/public/icon/gor.png)
![](/public/icon/pdf.png)
Keywords:
Anabolic steroids, Biotransformation, Boldenone, Camel liver, In vitro metabolism, HRMSAbstract
Anabolic steroids are widely abused in animal sports to improve their performance. The present study identifies the possible metabolites of boldenone in camel liver. A high-resolution accurate QE mass spectrometer was used to identify the parent boldenone and its metabolites. To investigate the phase 1 biotransformation of boldenone in camel, sodium phosphate buffer and NADPH were used. Chromatographic separation was carried out on a Thermo Hypersil C18 column using acetonitrile and formic acid as mobile phases. The current study, helped in unequivocal detection of six metabolites (Phase 1) for boldenone. The 17b-boldenone is an 3-oxo-Delta (1), Delta(4)-steroid substituted by an oxo group at position 3 and a beta-hydroxy group at position 17. It is prone to oxidation, which results in three hydroxylated metabolites with protonated parent ion of m/z 303.1954 (C19H27O3)+. Androsta-1,4-diene-3,17-dione [M+H]+ of m/z 285.1848 (C19H25O2+), hydroxyandrosta-1,4-diene-3,17-dione [M+H]+ of m/z 301.1797 (C19H25O3+) in addition to 17-hydroxy-androsta-1-en-3-one [M+H]+ of m/z 289.2162 (C19H29O2+) were also identified. The structures of the detected metabolites were identified based on their accurate mass, fragmentation pattern, and chromatographic retention time. In this research, camel liver was successfully used for in vitro experiments as an alternative to liver microsomes.
Downloads
References
Al Katheeri N A, Wasfi I A, Lambert M, Giuliano Albo A and Nebbia, C. 2006. In vivo and in vitro metabolism of dexamethasone in the camel. Veterinary Journal 172(3): 532–43. DOI: https://doi.org/10.1016/j.tvjl.2005.06.003
Balcells G, Pozo O J, Esquivel A, Kotronoulas A, Joglar J, Segura J and Ventura R. 2015. Screening for anabolic steroids in sports: Analytical strategy based on the detection of phase I and phase II intact urinary metabolites by liquid chromatography tandem mass spectrometry. Journal of Chromatography A 1389: 65–75. DOI: https://doi.org/10.1016/j.chroma.2015.02.022
Brandon E F A, Raap C D, Meijerman I, Beijnen J H and Schellens J H M. 2003. An update on in vitro test methods in human hepatic drug biotransformation research: Pros and cons. Toxicology and Applied Pharmacology 189(3): 233–46. DOI: https://doi.org/10.1016/S0041-008X(03)00128-5
Buiarelli F, Cartoni G P, Coccioli F, Giannetti L, Merolle M, Neri B and Terracciano A. 2005. Detection of boldenone and its major metabolites by liquid chromatography — tandem mass spectrometry in urine samples. Analytica Chimica Acta 552: 116–26. DOI: https://doi.org/10.1016/j.aca.2005.06.071
Cannizzo F T, Zancanaro G, Spada F, Mulasso C and Biolatti B. 2007. Pathology of the testicle and sex accessory glands following the administration of boldenone and boldione as growth promoters in veal calves. Journal of Veterinary Medical Science 69(11): 1109–16. DOI: https://doi.org/10.1292/jvms.69.1109
De Brabander H F, Poelmans S, Schilt R, Stephany R W, Le Bizec B, Draisci R, Sterk S S, van Ginkel L A, Courtheyn D, Van Hoof N, Macrì A and De Wasch K. 2004. Presence and metabolism of the anabolic steroid boldenone in various animal species: A review. Food Additives and Contaminants 21(6): 515–25. DOI: https://doi.org/10.1080/02652030410001687717
Fred Hartgens, Wouter D. Van Marken Lichtenbelt, Spike Ebbing, Niels Vollaard, Gerard Rietjens and Harm Kuipers. 2001. Androgenic-anabolic steroid—induced body changes in strength athletes. The Physician and Sportsmedicine 29(1): 49–46. DOI: https://doi.org/10.3810/psm.2001.01.316
IARC I A for R on C. 1987. Evaluation of carcinogenic risks. Overall evaluations of carcinogenicity: IARC Monographs, 1–42.
Mayada R F, Taghred M S and Haytham A A. 2015. Boldenone-induced apoptotic, structural, and functional alterations in the liver of rabbits. World Rabbit Science 23(1): 39–46. DOI: https://doi.org/10.4995/wrs.2015.2261
Merlanti R, Gallina G, Capolongo F, Contiero L, Biancotto G, Dacasto M and Montesissa C. 2007. An in vitro study on metabolism of 17β-boldenone and boldione using cattle liver and kidney subcellular fractions. Analytica Chimica Acta 586(1-2 SPEC. ISS.): 177–83. DOI: https://doi.org/10.1016/j.aca.2006.12.007
Nielen M W F, Rutgers P, Van Bennekom E O, Lasaroms J J P and Van Rhijn J A. 2004. Confirmatory analysis of 17β-boldenone, 17α-boldenone and androsta-1,4-diene-3,17- dione in bovine urine, faeces, feed and skin swab samples by liquid chromatography-electrospray ionisation tandem mass spectrometry. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 801(2): 273–83. DOI: https://doi.org/10.1016/j.jchromb.2003.11.026
Philip M, Karakka Kal A K, Subhahar M B, Karatt T K, Mathew B and Perwad Z. 2022. In vitro studies of hypoxia inducible factor-prolyl hydroxylase inhibitors daprodustat, desidustat, and vadadustat for equine doping control. Drug Testing and Analysis 14(2): 317–48. DOI: https://doi.org/10.1002/dta.3188
Philip M, Karakka Kal A K, Subhahar M B, Perwad Z and Karatt T K. 2021. Characterization of equine liver microsome-generated metabolites of growth hormone secretagogue small molecule ibutamoren. Rapid Communications in Mass Spectrometry 35(23). DOI: https://doi.org/10.1002/rcm.9201
Philip M, Mathew B, Karatt T K, Perwad Z, Subhahar M B and Karakka Kal A K. 2021. Metabolic studies of hypoxia-inducible factor stabilisers IOX2, IOX3 and IOX4 (in vitro) for doping control. Drug Testing and Analysis 13(4): 794–816. DOI: https://doi.org/10.1002/dta.3000
Popot M A, Stojiljkovic N, Garcia P, Bonnaire Y and Tabet J C. 2003. First mass spectrometric detection of boldenone in horse mane samples. Chromatographia 57(3–4): 255–60. DOI: https://doi.org/10.1007/BF02491725
Schanxer W and Domke M. 1993. Metabolism of anabolic steroids in man: synthesis and use of reference substances for identification of anabolic steroid metabolites. Analytica Chimica Acta 275: 23–48. DOI: https://doi.org/10.1016/0003-2670(93)80274-O
Soma L R, Uboh C E, Guan F, Mcdonnell S and Pack J. 2007. Pharmacokinetics of boldenone and stanozolol and the results of quantification of anabolic and androgenic steroids in race horses and nonrace horses. Journal of Veterinary Pharmacology and Therapeutics 30(2): 101–08. DOI: https://doi.org/10.1111/j.1365-2885.2007.00824.x
Van Puymbroeck M, Kuilman M E M, Maas R F M, Witkamp R F, Leyssens T, Vanderzande D, Gelan J and Raus J. 1998. In vitro liver models are important tools to monitor the abuse of anabolic steroids in cattle. Analyst 123(12): 2453–56. DOI: https://doi.org/10.1039/a805013i
Van Puymbroeck Mark, Kuilman M E M, Maas R F M, Witkamp R F, Leyssens L, Vanderzande D, Gelan J and Raus J. 1998. Identification of some important metabolites of boldenone in urine and feces of cattle by gas chromatography-mass spectrometry. Analyst 123(12): 2681–86. DOI: https://doi.org/10.1039/a805003a
Verheyden K, Noppe H, Zorn H, Van Immerseel F, Bussche J Vanden, Wille K, Bekaert K, Janssen C R, De Brabander H F and Vanhaecke L. 2010. Endogenous boldenone-formation in cattle: Alternative invertebrate organisms to elucidate the enzymatic pathway and the potential role of edible fungi on cattle’s feed. Journal of Steroid Biochemistry and Molecular Biology 119(3–5): 161–70. DOI: https://doi.org/10.1016/j.jsbmb.2010.02.020
Downloads
Submitted
Published
Issue
Section
License
The copyright of the articles published in The Indian Journal of Animal Sciences is vested with the Indian Council of Agricultural Research, which reserves the right to enter into any agreement with any organization in India or abroad, for reprography, photocopying, storage and dissemination of information. The Council has no objection to using the material, provided the information is not being utilized for commercial purposes and wherever the information is being used, proper credit is given to ICAR.